Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Gastroenterology|June 23, 2026
BIRC3 (Encoding Cellular Inhibitor of Apoptosis Protein 2) Variants Result in Dysregulated Receptor-Interacting Protein Kinase 1 Signaling Leading to Increased Epithelial Cell Death and Are Associated With Monogenic Crohn's DiseaseQi Li, Ryusuke Nambu, Hu Yaqiang, et al.
The Journal of Experimental Medicine|February 5, 2021
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccinePaul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCsMonique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2021
Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 DeficiencyTom Le Voyer, Sonoko Sakata, Miyuki Tsumura, et al.
Science Translational Medicine|August 25, 2021
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Science Immunology|February 10, 2023
Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteriaQuentin Philippot, Masato Ogishi, Jonathan Bohlen, et al.
Cell|October 24, 2023
Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteriaJonathan Bohlen, Qinhua Zhou, Quentin Philippot, et al.
Cell|May 7, 2026
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infectionsMorgane Fournier, Matthias Vanderkerken, Karim Dorgham, et al.
The Journal of Experimental Medicine|June 22, 2023
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patientsAdrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
The Journal of Experimental Medicine|April 23, 2021
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1Paul Bastard, Elizaveta Orlova, Leila Sozaeva, et al.
Pageof 7